Update on the Stanley Foundation Schizophrenia Treatment Network

UPDATE ON THE STANLEY

FOUNDATION SCHIZOPHRENIA TREATMENT NETWORK

Michael B. Knable

Stanley Foundation, Bethesda, MD

Despite many new advances in the

psychopharmacology of schizophrenia, the majority of patients

suffer from residual symptoms even with optimal treatment. In

order to stimulate novel approaches to the management of these

symptoms, the Stanley Foundation is organizing a multi-site,

collaborative investigation of new treatments. The current goals

and structure of the network will be described. Potential

candidate drugs for study will also be presented.